Pg. Cavero et al., EFFECT OF ORTHOTOPIC CARDIAC TRANSPLANTATION ON PERIPHERAL VASCULAR FUNCTION IN CONGESTIVE-HEART-FAILURE - INFLUENCE OF CYCLOSPORINE THERAPY, The American heart journal, 127(6), 1994, pp. 1581-1587
The objective of this study was to examine peripheral vascular functio
n before and after cardiac transplantation and to assess the effect of
immunosuppressive therapy on peripheral vascular reactivity. Peripher
al vascular function abnormalities present in congestive heart failure
may be reversed with cardiac transplantation, but immunosuppressive t
herapy may alter these changes in the peripheral vasculature. Venous o
cclusion plethysmography was used to study peripheral vascular functio
n in nine patients with severe congestive heart failure who underwent
cardiac transplantation. Forearm blood flow and forearm vascular resis
tance were measured:in patients with congestive heart failure in respo
nse to cold stimulation, maximal hyperemia, and hand grip exercise (1)
before transplantation; (2) 24 to 36 hours posttransplantation before
the commencement of cyclosporine; (3) 6 to 8 days posttransplantation
in the presence of therapeutic cyclosporine levels; and (4) 6 weeks p
osttransplantation. Venous capacitance was also measured. After cardia
c transplantation, mean arterial pressure increased and remained eleva
ted. Forearm blood flow initially increased after transplantation but
subsequently decreased with cyclosporine. Cold-induced reflex sympathe
tic activation decreased immediately after transplantation but was sig
nificantly enhanced with cyclosporine. The maximal vasodilatory respon
se following ischemic cuff occlusion and with 5 minutes of isometric h
and grip exercise increased significantly after transplantation and re
mained improved at 6 weeks. Thus after cardiac transplantation, periph
eral vasodilator function improves and is not altered by cyclosporine.
However, with cyclosporine therapy resting forearm vascular resistanc
e increases and reflex sympathetic vasoconstriction is enhanced, sugge
sting that cyclosporine may potentiate adrenergic-mediated peripheral
vasoconstriction and thus may contribute to posttransplant hypertensio
n.